U.K. chip designer Arm Holdings Plc is looking to expand its hold on the automotive chip industry with a new and integrated design platform that promises to increase the time it takes to bring ...

It isn't as if it seemed remotely likely to us, but recent speculation has suggested Microsoft could be looking at an ARM chip for the 'real' Xbox handheld.

Arm is rebranding its system-on-a-chip product designs to showcase power savings for AI workloads, targeting a surprising sector Carl Franzen @carlfranzen May 15, 2025 9:17 AM ...

A Santa Barbara County Superior Court judge late last week denied the California Coastal Commission's request for a temporary restraining order to block Sable Offshore's (NYSE: SOC) maintenance ...

Smart devices will get microchips with integrated blockchain technology thanks to a new partnership between a lightweight layer-1 blockchain and global chip designer Arm.

Meta wants to make artificial intelligence available to everyone who uses its platforms, but scaling AI to over one billion people is not going to be cheap.

SMARC iMX8M Plus block diagram Key features of the SMARC iMX95 module: SoC – NXP i.MX 9596 CPU Up to 6x Arm Cortex-A55 application cores clocked at 1.8 GHz (industrial) with 32K I-cache and D-cache, ...

The development arm of Tokenize Xchange has acquired blockchain intelligence platform Coinseeker at a valuation of $30 million. Titan Lab plans to incorporate Coinseeker's AI-powered analytics ...

British chip design firm Arm Holdings (ARM) has discussed raising prices as much as 300%, Reuters reported. Read for more.

Hardware Processors Nvidia seems to have just confirmed upcoming Arm and Blackwell laptop chips based on its new GB10 processor in collaboration with MediaTek News By Jacob Fox published January 9 ...

Arm says it’s losing $50M a year in revenue from Qualcomm’s Snapdragon X Elite SoCs At issue: Arm SoC designs that Qualcomm acquired when it bought Nuvia in 2021.

Cardiff Oncology CRDF announced robust efficacy data from an ongoing mid-stage study evaluating two doses of its lead investigational candidate, onvansertib (20 mg and 30 mg), in combination with ...